Medicine information
उपयोग
Ceftriaxone & Tazobactam for Injection 1125 mg is an injectable antibiotic combination intended for the treatment of certain bacterial infections when prescribed by a qualified healthcare professional. Ceftriaxone belongs to the cephalosporin class of antibiotics and acts by inhibiting bacterial cell wall synthesis, which helps eliminate susceptible bacteria. Tazobactam inhibits certain beta-lactamase enzymes produced by bacteria, helping protect susceptible beta-lactam antibiotics from enzymatic breakdown. This combination may be considered for selected bacterial infections, depending on the infection site, local antimicrobial guidelines, laboratory results, and the susceptibility of the causative organism. The specific approved indications can vary by manufacturer and country. It is not effective against viral infections such as the common cold or influenza, and its use should be guided by an appropriate clinical assessment. Ceftriaxone & Tazobactam for Injection 1125 mg must be administered by a qualified healthcare professional using the prescribed route and dose. The duration of treatment depends on the type and severity of infection, patient response, and relevant clinical findings. Possible adverse effects include diarrhoea, nausea, injection-site reactions, and allergic reactions. Serious complications can include severe hypersensitivity, antibiotic-associated colitis, and blood-related abnormalities. Patients with a history of severe allergy to cephalosporins, penicillins, or other beta-lactam antibiotics should inform their doctor before treatment. For healthcare facilities and eligible purchasers searching for Ceftriaxone & Tazobactam for Injection 1125 mg online in India, verify the exact composition, manufacturer, packaging, storage requirements, expiry date, and applicable prescription requirements before purchase. Responsible antibiotic use is essential to help reduce antimicrobial resistance.
कैसे उपयोग करें
Confirm the prescription: Check the medicine name, strength, prescribed dose, route, and frequency with the treating clinician before administration. Use professional administration: This injectable antibiotic must be prepared and administered by trained healthcare personnel. Do not attempt to prepare or inject it yourself without appropriate professional training and explicit medical instructions. Follow preparation instructions: The healthcare professional should reconstitute and, if necessary, dilute the medicine according to the manufacturer's approved instructions. Only compatible diluents and administration methods should be used. Confirm the administration route: The appropriate route depends on the specific product's approved instructions. Do not assume that every formulation is suitable for every injectable route. Discuss allergies: Inform the doctor about previous reactions to ceftriaxone, cephalosporins, penicillins, or other beta-lactam antibiotics. Seek immediate help if breathing difficulties, facial swelling, or a severe allergic reaction develops. Review your medical history: Tell your healthcare provider about kidney disease, liver problems, gastrointestinal disorders, blood disorders, pregnancy, breastfeeding, and all medicines you take. Complete the prescribed course: Continue treatment for the duration determined by your doctor. Do not stop early, extend treatment, or request additional doses without medical advice. Monitor for side effects: Report persistent diarrhoea, severe abdominal pain, unusual bruising, rash, or worsening symptoms. Severe or bloody diarrhoea requires prompt medical assessment. Attend follow-up appointments: Your doctor may review your symptoms, laboratory results, kidney function, blood counts, or culture reports to assess whether treatment is working. Store the product correctly: Follow the manufacturer's storage requirements for the unopened product and any prepared solution. Preparation, stability, and use-after-reconstitution instructions vary by formulation. Avoid inappropriate antibiotic use: Do not share this medicine with another person or use leftover antibiotics. The treatment must be selected according to the suspected or confirmed bacterial infection.
